Logo image of TSVT

2SEVENTY BIO INC (TSVT) Stock Analyst Earnings Estimates

NASDAQ:TSVT - Nasdaq - US9013841070 - Common Stock - Currency: USD

5  +0.01 (+0.2%)

After market: 5 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
TSVT revenue by date.TSVT revenue by date.
91.5M
67.89%
100.387M
9.71%
37.862M
-62.28%
69.849M
84.48%
76.618M
9.69%
80.932M
5.63%
85.797M
6.01%
89.449M
4.26%
111.4M
24.54%
102.62M
-7.88%
109.26M
6.47%
EBITDA
YoY % growth
TSVT ebitda by date.TSVT ebitda by date.
-241.97M
15.82%
-206.653M
14.60%
-91.478M
55.73%
-42.541M
53.50%
-6.456M
84.82%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
TSVT ebit by date.TSVT ebit by date.
-253.5M
16.56%
-216.938M
14.42%
-98.574M
54.56%
-32.64M
66.89%
-12.497M
61.71%
128.01K
101.02%
-6.936M
-5,518.33%
4.998M
172.06%
22.848M
357.14%
N/AN/A
Operating Margin
TSVT operating margin by date.TSVT operating margin by date.
-277.05%-216.10%-260.35%-46.73%-16.31%0.16%-8.08%5.59%20.51%N/AN/A
EPS
YoY % growth
TSVT eps by date.TSVT eps by date.
-7.58
44.11%
-4.02
46.99%
-1.12
72.14%
-0.47
58.41%
-0.24
48.91%
0.28
215.72%
0.42
51.85%
0.61
46.34%
0.91
48.33%
N/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.17
82.83%
-0.15
-134.00%
-0.08
58.88%
-0.02
93.57%
Revenue
Q2Q % growth
14.242M
84.29%
13.701M
52.79%
15.911M
17.56%
18.054M
517.02%
EBITDA
Q2Q % growth
-13.475M
69.08%
-9.618M
39.47%
-6.239M
21.98%
N/A
EBIT
Q2Q % growth
-14.388M
68.51%
-12.14M
38.28%
-7.897M
41.24%
-4.794M
75.75%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth

82.83%
-0.17%
Q4 2024
Q2Q % growth
-0.37
66.67%
-0.27-0.10-36.88%
Q3 2024
Q2Q % growth
-0.19
81.00%
-0.250.0622.77%
Q2 2024
Q2Q % growth
0.45
154.22%
-0.661.11168.10%
Q1 2024
Q2Q % growth
-1.01
6.48%
-0.83-0.18-21.92%
Q4 2023
Q2Q % growth
-1.11
-85.00%
-1.01-0.10-9.91%
Q3 2023
Q2Q % growth
-1.00
43.18%
-1.050.054.66%
Q2 2023
Q2Q % growth
-0.83
58.91%
-1.090.2623.59%
Q1 2023
Q2Q % growth
-1.08
66.29%
-1.220.1411.27%
Q4 2022
Q2Q % growth
-0.60
76.47%
-1.641.0463.37%
Q3 2022
Q2Q % growth
-1.76
32.82%
-1.840.084.40%
Q2 2022
Q2Q % growth
-2.02 -2.320.3012.99%
Q1 2022
Q2Q % growth
-3.20 -2.10-1.11-52.93%
Q4 2021
Q2Q % growth
-2.55 -2.890.3411.85%
Q3 2021
Q2Q % growth
-2.62 -2.760.145.22%
TSVT Yearly EPS VS EstimatesTSVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -5 -10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
22.917M
84.29%
14.242M8.675M60.91%
Q4 2024
Q2Q % growth
2.926M
-72.61%
12.538M-9.612M-76.66%
Q3 2024
Q2Q % growth
13.534M
12.46%
15.337M-1.803M-11.76%
Q2 2024
Q2Q % growth
8.967M
-75.12%
14.479M-5.512M-38.07%
Q1 2024
Q2Q % growth
12.435M
-70.12%
14.367M-1.932M-13.45%
Q4 2023
Q2Q % growth
10.684M
-80.98%
15M-4.316M-28.77%
Q3 2023
Q2Q % growth
12.034M
-10.26%
31.8M-19.766M-62.16%
Q2 2023
Q2Q % growth
36.048M
167.42%
37.616M-1.568M-4.17%
Q1 2023
Q2Q % growth
41.621M
393.72%
22.751M18.87M82.94%
Q4 2022
Q2Q % growth
56.18M
250.47%
15.83M40.35M254.90%
Q3 2022
Q2Q % growth
13.41M
-30.37%
12.613M797K6.32%
Q2 2022
Q2Q % growth
13.48M
-29.90%
16.849M-3.369M-20.00%
Q1 2022
Q2Q % growth
8.43M 23.114M-14.684M-63.53%
Q4 2021
Q2Q % growth
16.03M
-93.54%
13.179M2.851M21.63%
Q3 2021
Q2Q % growth
19.26M 8.71M10.55M121.13%
Q2 2021
Q2Q % growth
19.229M
-91.25%
%
TSVT Yearly Revenue VS EstimatesTSVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -15.65% 0% -14.28%
Revenue0% 5.4% 0% 4.24%